CAPMAN PLC SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CAPMAN PLC SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY EXCHANGE OFFER FOR ALL NORVESTIA OYJ’S SHARES AND SECURITIES ENTITLING TO SHARES

Helsinki, Finland, 2016-12-08 15:45 CET (GLOBE NEWSWIRE) --  

Norvestia Oyj           Stock Exchange Release  8 December 2016 at 16:45

This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in the United States of America, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, or any other country where such publication or distribution would violate applicable regulation or would require additional measures in addition to the requirements under Finnish law.

CAPMAN PLC SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY EXCHANGE OFFER FOR ALL NORVESTIA OYJ’S SHARES AND SECURITIES ENTITLING TO SHARES

CapMan Plc (“CapMan”) has 3 November 2016 announced, in the manner provided in Chapter 11 of the Finnish Securities Markets Act (746/2012, as amended), a voluntary public exchange offer (the “Exchange Offer”) to acquire all Norvestia Oyj’s (“Norvestia”) shares and securities entitling to shares.

CapMan commenced the Exchange Offer 21 November 2016 and published the tender offer document relating to the Exchange Offer 18 November 2016 (“Tender Offer Document”). Norvestia announced 7 December 2016 an increase in its Net Asset Value and a supplement to the Board statement relating to the Exchange Offer, in which the Board maintains its recommendation.

CapMan has today 8 December published a stock exchange release, pursuant to which the Finnish Financial Supervisory Authority has approved the supplement to the Tender Offer Document concerning the Board of Directors of Norvestia having supplemented its statement. CapMan’s stock exchange release in its entirety is attached as an Appendix to this stock exchange release.

Helsinki, 8 December 2016

NORVESTIA OYJ

Board of Directors

Additional information: Hannu Syrjänen, Vice Chairman of the Board tel. +358 400 454 885

Distribution: Nasdaq Helsinki Main media www.norvestia.fi

Appendix: CapMan Plc’s stock exchange release 8 December 2016

Important Notice

This release may not be released or otherwise distributed, in whole or in part, in or into or to any person located or a resident of the United States of America, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or any other jurisdiction where prohibited by applicable laws or rules. This release is not a share exchange offer document or a prospectus and as such does not constitute an offer or invitation to make a sales offer. Investors shall accept the exchange offer for the shares only on the basis of the information provided in an exchange offer document and prospectus in respect of the exchange offer. Offers will not be made directly or indirectly in any jurisdiction where either an offer or participation therein is prohibited by applicable law or where any exchange offer document or registration or other requirements would apply in addition to those undertaken in Finland.

The exchange offer document and prospectus in respect of the exchange offer as well as related acceptance forms will not and may not be distributed, forwarded, or transmitted into, in, or from any jurisdiction where prohibited by applicable law. In particular, the exchange offer is not being made, directly or indirectly, in or into, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, or the United States of America. The exchange offer cannot be accepted from within Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, or the United States of America.

CapMan’s shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or under any of the relevant securities laws of any state or other jurisdiction of the United States of America. CapMan's shares may not be offered or sold in the United States, except pursuant to an exemption from the Securities Act or in a transaction not subject to the registration requirements of the Securities Act.

Certain statements herein which are not historical facts, including, without limitation, those regarding expectations for general economic development and the market situation, expectations for the combined company’s development and profitability and the realization of synergy benefits and cost savings, and statements preceded by “expects”, ”estimates”, ”forecasts” or similar expressions, are forward-looking statements. These statements are based on current decisions and plans and currently known factors. They involve risks and uncertainties which may cause the actual results to materially differ from the results currently expected for the combined company. Such factors include, but are not limited to, general economic conditions, including fluctuations in exchange rates and interest levels which influence the operating environment and profitability of customers and thereby the orders received by the combined company and their margin; the competitive situation; the combined company’s own operating conditions, such as the success of production and product development and their continuous development and improvement; and the success of future acquisitions.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BIBIBOP Brings Good Vibes with OLIPOP Happy Hour

Updated Category News Views 131

Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 97

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 169

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
Cardinal Infrastructure Faces Legal Scrutiny Amid Losses

Updated Category News Views 125

Cardinal Infrastructure Group Under Intense Investor Scrutiny Well, ain't this a messy soup of financial blunders? Cardinal Infrastructure Group (Nasdaq: CDNL) finds itself on the sharp end of a potential securities law investigation, thanks to some colossal screw-ups in managing project costs and estimates. Investors are rightly pissed after the company's shares...

Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery

Updated Category News Views 227

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 137

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 108

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 219

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Purdue's xGTT: Pioneering a New Trust Standard in Tech

Updated Category News Views 150

A Bold New Benchmark in Tech Trust You've got to hand it to the folks at Purdue's Krach Institute—they're not dancing around the fringes but diving straight into the thick of it with their Global Trusted Tech Standard, or xGTT. This isn't just another checkbox for compliance nerds. The xGTT is all about building trust in technology that's woven with democratic values...

Continue Reading

Top 5 Most Recently Viewed Articles

HawkEye 360 Expands Capabilities with Strategic NRO Partnership

Updated Category News Views 189

HawkEye 360's New Partnership with the NRO HawkEye 360, recognized as a leader in sharing signals intelligence data and analytics, has recently secured a significant funding extension from the National Reconnaissance Office (NRO) alongside the Commercial Systems Program Office (CSPO). This collaborative effort is set to span over 23 months, aiming to enhance the...

Continue Reading
Consumer Sentiment and Its Impact on Economic Reflation Trends

Updated Category News Views 88

Understanding Consumer Sentiment Trends In recent discussions, we have explored how indicators like inflation gauges can influence economic forecasts. A notable aspect is consumer sentiment, which provides insights into spending behaviors and overall market confidence. Recent readings suggest a surprising optimism among consumers, especially in light of complex inflation...

Continue Reading
Ocular Therapeutix Announces Major Stock Offering Ahead of Trials

Updated Category News Views 264

Ocular Therapeutix's Strategic Stock Offering Announcement Ocular Therapeutix, Inc. (Nasdaq: OCUL), known for its commitment to enhancing retinal health, has declared an exciting new chapter in its journey. The company has recently confirmed the pricing for an underwritten public offering of 37,909,018 shares of its common stock, set at $12.53 per share. This significant...

Continue Reading
Roku Ads Manager: Innovations for Today’s Marketing Landscape

Updated Category News Views 145

Roku Unveils Ads Manager for Growth-Driven Marketers Roku (NASDAQ: ROKU) has stepped up its game in the streaming industry by launching a new platform named Roku Ads Manager. This self-service tool is tailored specifically for marketers eager to improve their connected television (CTV) campaigns. The rollout of this innovative platform comes as advertising trends shift...

Continue Reading
Evaxion Secures $10.8 Million in Strategic Public Offering

Updated Category News Views 97

Evaxion Biotech's Recent Public Offering Evaxion Biotech A/S (NASDAQ: EVAX) has recently made headlines with its announcement of a public offering. The company, renowned for its pioneering work in AI-Immunology™, has set the offering's combined public price at $2.71 per ADS, with warrants allowing the purchase of equal representation. This promising move emphasizes...

Continue Reading